Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Immunoglobulin Light-chain Amyloidosis 3Amyloidosis 2Amyloidosis, Familial 1AA amyloidosis 1

Interventions

Dexamethasone 21Calcium Dobesilate 10Melphalan 9Bortezomib 8Cyclophosphamide 7Lenalidomide 6pomalidomide 4venetoclax 3miridesap 3daratumumab 3ixazomib 2belantamab mafodotin 2Thalidomide 2Doxycycline 2Biopsy 24-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene 2selinexor 1pegfilgrastim 1isatuximab 1dexamethasone acetate 1dexamethasone 21-phosphate 1carfilzomib 1birtamimab 1auricularum 1Vinorelbine 1Technetium Tc 99m Pyrophosphate 1Technetium 1Tacrolimus 1Surveys and Questionnaires 1Pharmaceutical Preparations 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Amyloidosis × Doxycycline × Plasma cell × Clear all
NCT02207556 2021-07-09

DUAL

Medical College of Wisconsin

Phase 2 Completed
32 enrolled 15 charts
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT01677286 2017-08-01

Safety and Effect of Doxycycline in Patients With Amyloidosis

Boston University

Phase 2 Completed
25 enrolled 13 charts
Plasma cell

AA amyloidosis, Immunoglobulin Light-chain Amyloidosis, Amyloidosis, Amyloidosis, Familial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡